---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-009063"
form_type: "8-K"
ticker: "BBIO"
cik: "0001743881"
company_name: "BridgeBio Pharma, Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:56:05.048667+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BridgeBio Pharma appoints Thomas Trimarchi as President and CFO; former CFO departs

## Summary
- Brian Stephenson's employment ended March 17, 2025; receives 9 months base salary and COBRA.
- Stephenson to serve as consultant from March 17, 2025 through March 17, 2026.
- Thomas Trimarchi appointed President and CFO; effective immediately.
- Stephenson's departure is for personal reasons and not due to any disagreement with the company.

## SEC filing metadata
- accession: 0001140361-25-009063
- form_type: 8-K
- ticker: BBIO
- cik: 0001743881
- company_name: BridgeBio Pharma, Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/0001140361-25-009063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/ef20045625_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-009063
- JSON: https://secwatch.observer/filing/0001140361-25-009063.json
- Plain text: https://secwatch.observer/filing/0001140361-25-009063.txt

## Key facts
- Executive change
  Brian C. Stephenson departed as Chief Financial Officer at BridgeBio Pharma, Inc..
  - Action: ended
  - Role: Chief Financial Officer
  source text: The employment of Brian C. Stephenson, the Chief Financial Officer of BridgeBio Pharma, Inc. (the “Company”), ended on March 17, 2025 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1743881/000114036125009063/0001140361-25-009063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.